BPC-157 is not Federally Approved or Pharmacy Grade
This experiment will provide evidence that BPC 157 treatment can recover tail function, resolve spasticity, and improve neurologic recovery
however, the trial was powered to only detect much larger reductions
scholarship from Abbott Medical, Boehringer Ingelheim Japan, Daiichi Sankyo Healthcare, Mitsubishi Tanabe, and Teijin
Beatty, S., Koh, H., Phil, M., Henson, D
The 2025 Zdrada-Nowak review in International Journal of Molecular Sciences confirmed the clinical evidence for AH-8 in wrinkle reduction, elasticity, and hydration, but flagged the specific limitation that low intrinsic skin penetration is the main efficacy ceiling for topical use [12]